Overview
This course examines the physiology, pharmacology, and clinical application of hormonal modulation in male gestational science, obstetrics, and perinatal care. It covers hypothalamic-pituitary-gonadal regulation, gestational tissue development, pelvic and abdominal implantation biology, endocrine preparation for gestation, placental signaling, labor-related hormonal changes, and postpartum endocrine transition.
Students evaluate gonadotropins, gonadotropin-releasing hormone analogues, antiestrogens, aromatase inhibitors, progesterone, estrogen, human chorionic gonadotropin, androgen-related therapies, insulin-sensitizing agents, and medications used in gestational preservation and reproductive care. Clinical applications include implantation support, controlled gestational tissue development, prevention of premature endocrine transition, postpartum hormonal stabilization, and management of endocrine conditions affecting male pregnancy.
Emphasis is placed on dose selection, treatment sequencing, ultrasound and biochemical monitoring, pharmacokinetics, contraindications, adverse effects, gestational hyperstimulation syndrome, multiple gestation risk, and medication safety. Students apply current evidence and ethical principles to interpret endocrine profiles, compare treatment protocols, assess treatment response and risk, design monitoring plans, and justify patient-centered therapeutic adjustments.
Learning Outcomes
- Analyze hypothalamic-pituitary-gonadal and placental endocrine regulation during male gestation.
- Explain the mechanisms of action, pharmacokinetics, therapeutic uses, and adverse effects of hormonal modulation agents.
- Interpret endocrine profiles, ultrasound findings, and biochemical monitoring data in gestational care.
- Compare hormonal treatment protocols for implantation support, gestational tissue development, endocrine dysfunction, and postpartum stabilization.
- Evaluate contraindications, medication interactions, hyperstimulation, multiple gestation, and other treatment-related risks.
- Design monitoring plans that integrate clinical findings, laboratory data, imaging, and treatment milestones.
- Justify patient-centered adjustments to hormonal therapy using current evidence, ethical practice, and pharmacological safety principles.
Timetable
| Type | Length | Frequency | Period |
|---|---|---|---|
| Lecture | 2 hours | Weekly | All semester |
| Lab | 2 hours | Weekly | All semester |
| Tutorial | 1 hour | Fortnightly | All semester |
| Practicum | 2 hours | Fortnightly | Second term |
Assessment Schedule
| Type | Description | Weighting |
|---|---|---|
| Assignment | Endocrine case analysis | 20.00% |
| Quiz | Protocol knowledge quizzes (4 × 5%) | 20.00% |
| Test | Pharmacology and monitoring test | 25.00% |
| Deliverable | Clinical simulation and treatment plan | 15.00% |
| Exam | Final written examination | 20.00% |
Teaching Staff & Programs
This course is delivered jointly by faculty from the participating programs listed below. In line with the Douchewater Way, the University of Sexology tailors core instruction directly to each cohort's specific discipline — adapting curriculum to program needs rather than forcing students into a one-size-fits-all model. Learn more about our approach at The Douchewater Way.